Sequence analysis of mutA and mutM genes involved in the biosynthesis of the lantibiotic mutacin II in Streptococcus mutans

Gene

Volumn 206, Issue 1, 1998, Pages 37-43

  Woodruff, Wendy A ^a   Novak, Jan ^a   Caufield, Page W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antimicrobial peptide; Bacteriocin; Nucleotide sequence; Post translational modification

Indexed keywords

BACTERIOCIN; LACTICIN 481; LANTIBIOTIC; MUTACIN II; OLIGONUCLEOTIDE; SALIVARICIN; SIGNAL PEPTIDE; STREPTOCOCCIN A; UNCLASSIFIED DRUG; VARIACIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBIOTIC BIOSYNTHESIS; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DISRUPTION; LACTOCOCCUS LACTIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; STREPTOCOCCUS MUTANS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOCINS; BASE SEQUENCE; DNA, BACTERIAL; GENES, BACTERIAL; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PEPTIDES; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; STREPTOCOCCUS MUTANS;

BACTERIA (MICROORGANISMS); LACTOCOCCUS LACTIS; POSIBACTERIA; PROKARYOTA; STREPTOCOCCUS MUTANS;

EID: 0032484693     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(97)00578-7     Document Type: Article

References (37)

1. Caufield P.W., Childers N.K., Allen D.N., Hansen J.B. Distinct bacteriocin groups correlate with different groups of Streptococcus mutans plasmids. Infect. Immun. 48:1985;51-56.
2. Caufield P.W., Shah G., Hollingshead S.K., Parrot M., Lavoie M.C. Evidence that mutacin II production is not mediated by a 5.6-kb plasmid in Streptococcus mutans. Plasmid. 24:1990;110-118.
3. Caufield P.W., Shah G.R., Hollingshead S.K. Use of transposon Tn916 to inactivate and isolate a mutacin-associated gene from Streptococcus mutans. Infect. Immun. 58:1990;4126-4135.
4. Chikindas M.L., Novak J., Driessen A.J.M., Konings W.N., Schilling K.M., Caufield P.W. Mutacin II, a bactericidal lantibiotic from Streptococcus mutans. Antimicrob. Agents Chemother. 39:1995;2656-2660.
5. de Vos W.M., Kuipers O.P., van der Meer J.R., Siezen R.J. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by Gram-positive bacteria. Mol. Microbiol. 17:1995;427-437.
6. Hamada S., Ooshima T. Inhibitory spectrum of a bacteriocin-like substance (mutacin) produced by some strains of Streptococcus mutans. J. Dent. Res. 54:1975;140-145.
7. Hamada S., Ooshima T. Production and properties of bacteriocins (mutacins) from Streptococcus mutans. Arch. Oral Biol. 20:1975;641-648.
8. Hamada S., Slade H.D. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol. Rev. 44:1980;331-384.
9. Håvarstein L.S., Coomaraswamy G., Morrison D.A. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA. 92:1995;11140-11144.
10. Håvarstein L.S., Diep D.B., Nes I.F. A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol. Microbiol. 16:1995;229-240.
11. Hillman J.D., Dzuback A.L., Andrews S.W. Colonization of the human oral cavity by a Streptococcus mutans mutant producing increased bacteriocin. J. Dent. Res. 66:1987;1092-1094.
12. Hynes W.L., Ferretti J.P., Tagg J.R. Cloning of the gene encoding streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl. Environ. Microbiol. 59:1993;1969-1971.
13. Jack R., Benz R., Tagg J., Sahl H.-G. The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur. J. Biochem. 219:1994;699-705.
14. Jung, G., 1991. Lantibiotics: a survey. In: Jung, G., Sahl, H.G. (Eds.), Nisin and Novel Lantibiotics. ESCOM Sci., Leiden, pp. 1-34.
15. Kelstrup J., Gibbons R.J. Bacteriocins from human and rodent streptococci. Arch. Oral Biol. 14:1969;251-258.
16. Loesche W.J. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 50:1986;353-380.
17. Macrina F., Evans R.P., Tobian J.A., Hartley D.L., Clewell D.B., Jones K.R. Novel shuttle plasmid vechicles for Escherichia-Streptococcus transgeneric cloning. Gene. 25:1983;145-150.
18. Maniatis, T., Fritsch, E.F., Sambrook, J., 1982. Molecular Cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Meyer C., Bierbaum G., Heidrich C., Reis M., Süling J., Iglesias-Wind M.I., Kempter C., Molitor E., Sahl H.-G. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur. J. Biochem. 232:1995;478-489.
20. Novak J., Caufield P.W., Miller E.J. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans. J. Bacteriol. 176:1994;4316-4320.
21. Novak, J., Chen, P., Kirk, M., Barnes, S., Jablonsky, M.J., Holaday, S.K., Krishna, N.R., Baker, J., Caufield, P.W., 1997a. Structure and activity of the lantibiotic mutacin II. Evidence for two domains? Advances in Gene Technology: Biomolecular design, form and function. Miami Nature Biotechnology Short Reports, Vol. 8, 87.
22. Novak J., Kirk M., Caufield P.W., Barnes S., Morrison K., Baker J. Detection of modified amino acids in lantibiotic peptide mutacin II by chemical derivatization followed by electrospray ionization mass spectroscopic analysis. Anal. Biochem. 236:1996;358-360.
23. Novak J., Novak L., Shah G., Woodruff W., Caufield P.W. Transposon mutagenesis: cloning of chromosomal DNA from the site of Tn916 insertion using polymerase chain reaction. Biotechnol. Techniques. 11:1997;51-54.
24. Parrot M., Caufield P.W., Lavoie M.C. Preliminary characterization of four bacteriocins from Streptococcus mutans. Can. J. Microbiol. 36:1990;123-130.
25. Piard J.-C., Kuipers O., Rollema H.S., Desmazeaud M.J., de Vos W.M. Structure, organization, and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J. Biol. Chem. 268:1993;16361-16368.
26. Pridmore D., Rekhif N., Pittet A.-C., Suri B., Mollet B. Variacin, a new lanthionine-containing bacteriocin produced by Micrococcus varians: comparison to lacticin 481 of Lactococcus lactis. Appl. Environ. Microbiol. 62:1996;1799-1802.
27. Rince A., Dufour A., Le Pogam S., Thuault D., Bourgeois C.M., Le Pennec J.P. Cloning, expression, and nucleotide sequence of genes involved in production of lactococcin DR, a bacteriocin from Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 60:1994;1652-1657.
28. Ross K.F., Ronson C.W., Tagg J.R. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl. Environ. Microbiol. 59:1993;2014-2021.
29. Sahl H.-G., Jack R.W., Bierbaum G. Lantibiotics: biosynthesis and biological activities of peptides with unique post-translational modifications. Eur. J. Biochem. 230:1995;827-853.
30. Shah G.R., Caufield P.W. Enhanced transformation of Streptococcus mutans by modifications in culture conditions. Anal. Biochem. 214:1993;343-346.
31. Shyamala V., Ames G.F.-L. Genome walking by single-specific-primer polymerase chain reaction: SSP-PCR. Gene. 84:1989;1-8.
32. Shyamala V., Ames G.F.-L. Genome walking by single specific primer-polymerase chain reaction. Meth. Enzymol. 217:1993;436-446.
33. Siegers K., Heinzmann S., Entian K.-D. Biosynthesis of lantibiotic nisin. Post-translational modification of its prepeptide occurs at a multimeric membrane-associated lanthionine synthase complex. J. Biol. Chem. 271:1996;12294-12301.
34. Siezen R.J., Kuipers O.P., de Vos W.M. Comparison of lantibiotic gene clusters and encoded proteins. Antonie van Leeuwenhoek. 69:1996;171-184.
35. von Heijne G. Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J. Mol. Biol. 225:1992;487-494.
36. Weerkamp A., Bongaerts L.L., Vogels G.D. Bacteriocins as factors in the in vitro interaction between oral streptococci in plaque. Infect. Immun. 16:1977;773-780.
37. Weerkamp A., Vogels G.D., Skotnicki M. Antagonistic substances produced by streptococci from human dental plaque and their significance in plaque ecology. Caries Res. 11:1977;245-256.